Fulcrum Therapeutics Financial Overview
Fulcrum Therapeutics's market cap is currently $796.92M. The company's EPS TTM is $-0.31; its P/E ratio is -10.31; Fulcrum Therapeutics is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
